INVEA
LIVE

Serial Number

97869600

Owner

Invea Therapeutics, Inc.

Attorney

Jonathan Harris

Filing Date

Apr 3, 2023

Add to watchlist:

No watchlists yet
View on USPTO

INVEA Trademark

Serial Number: 97869600

INVEA is a trademark filed by Invea Therapeutics, Inc. on April 3, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Invea Therapeutics, Inc. (2 trademarks)

2614 Boston Post Road, Suite #33AR
Guilford, CT 06437

Entity Type: 03

Trademark Details

Filing Date

April 3, 2023

Registration Date

Not Registered

Published for Opposition

August 19, 2025

Goods & Services

Pharmaceutical preparations and substances for the treatment of gastrointestinal and hepatobiliary diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders and diseases relating to the gut-brain axis, involving the central nervous system, enteric nervous system, immune system, gastrointestinal tract, and dermatology; chemical preparations for the treatment of inflammatory diseases and disorders, including the central nervous system, enteric nervous system, immune system, gastrointestinal tract and dermatologic diseases and disorders, including atopic dermatitis, chronic urticaria, and prurigo nodularis ; biological preparations for the treatment of inflammatory diseases and disorders, including the central nervous system, enteric nervous system, immune system, gastrointestinal tract and dermatologic diseases and disorders, including atopic dermatitis, chronic urticaria, and prurigo nodularis; Pharmaceutical preparations for the treatment of gastrointestinal and hepatobiliary diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and immune system-related disorders; Pharmaceutical preparations in the field of gastrointestinal and hepatobiliary diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and immune system-related disorders; all these goods/services excluding food supplements, dietetic food preparations and ingredients and other dietetic products; the mark is used as a house mark for the goods identified in the instant application

Biochemical preparations for the treatment of inflammatory diseases and disorders, including the central nervous system, enteric nervous system, immune system, gastrointestinal tract and dermatologic diseases and disorders, including atopic dermatitis, chronic urticaria, and prurigo nodularis; all these goods excluding food supplements, dietetic food preparations and ingredients and other dietetic products

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 14, 2026 EXRA
SOU EXTENSION 1 GRANTED
Apr 13, 2026 EX1G
SOU EXTENSION 1 FILED
Apr 13, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 13, 2026 EEXT
CORRECTED NOA E-MAILED
Oct 28, 2025 NOAC
POST PUBLICATION AMENDMENT - ENTERED
Oct 28, 2025 CHPB
ASSIGNED TO PETITION STAFF
Oct 23, 2025 APET
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 14, 2025 NOAM
TEAS POST PUBLICATION AMENDMENT RECEIVED
Sep 16, 2025 EPPA
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 19, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 19, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 13, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2025 CNSA
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Jan 14, 2025 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Jan 14, 2025 PARI
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Sep 11, 2024 AMPX
TEAS VOLUNTARY AMENDMENT RECEIVED
Sep 11, 2024 PARI
EXAMINER'S AMENDMENT ENTERED
Apr 19, 2024 XAEC
ASSIGNED TO LIE
Apr 19, 2024 ALIE
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 18, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 18, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 18, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 17, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 17, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 17, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 17, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 17, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 29, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 26, 2023 NWOS
NEW APPLICATION ENTERED
Apr 6, 2023 NWAP